LHP588
Asset
Inhibitor targeting Porphyromonas gingivalis lysine-gingipain
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- Not known
- 2
- Indications
- 1
- Trial
- 1
- Developer
Indications
2Alzheimer disease due to p. gingivalis
Phase 2, Recruiting, NCT06847321, clinicaltrials.gov, 8 Oct 2026
Alzheimer's disease
Phase 2, Recruiting, NCT06847321, clinicaltrials.gov, 8 Oct 2026
In the full profile
- Owner and partners1
- Trials1
- Competitors12
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.